Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKβ.

@article{Heyninck2014WithaferinAI,
  title={Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKβ.},
  author={Karen Heyninck and Maija Lahtela-Kakkonen and Pieter van der Veken and Guy Haegeman and Wim Vanden Berghe},
  journal={Biochemical pharmacology},
  year={2014},
  volume={91 4},
  pages={501-9}
}
The transcription factor NF-κB is one of the main players involved in inflammatory responses during which NF-κB becomes rapidly activated. However to maintain homeostasis, this NF-κB activation profile is only transient. Nevertheless deregulation of NF-κB activity is often observed and can lead to chronic inflammatory diseases as well as cancer. Therefore various research projects focus on the development of therapeutics that target the NF-κB activation pathway. One such compound is Withaferin… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 31 extracted citations

Similar Papers

Loading similar papers…